Previous Page  10 / 35 Next Page
Information
Show Menu
Previous Page 10 / 35 Next Page
Page Background

sequencing strategies

Sequencing strategies should be flexible; in some cases revisiting previous

agents may be the best approach

Shaw AT, et al. N Engl J Med 2016;374:54−61.

Crizotinib

Chemotherapy

Lorlatinib

Crizotinib

Ceritinib AUY922

Crizotinib

Biopsy

Biopsy

Biopsy

Biopsy

Months:

6

12

18

24

30

36

42

48

Effect of therapy

Before lorlatinib

Response to lorlatinib

Resistance to lorlatinib

Response to crizotinib

C1156Y

L1198F

C1156Y